Drugs

Juul in deal talks with three tobacco giants

Juul is looking for a new backer as FDA order banning its vaporette remains in limbo pending trial. Talks have included Philip Morris, Japan Tobacco Group, and Altria.

Johnson & Johnson fourth-quarter earnings down 25%

The company continues to see pressure on sales from staffing shortages at hospitals, which have limited growth in procedures using J&J products, while inflation has boosted expenses.

FDA takes tougher line on fast-tracked drugs

The Food and Drug Administration relies on preliminary data to make the decision, but asks companies to conduct follow-up studies to confirm that the drug works.

FDA approves Amylyx ALS drug

Amylyx says doctors will be able to prescribe Relyvrio immediately. The drugmaker anticipates prescriptions will be filled and shipped from specialty pharmacies within the next four to six weeks.